AEVOLVE is a decentralized platform for the medical industry. It offers the AEVOLVE Token (AVEX) to support breakthroughs in medical science, provides a launch and distribution model for companies, and helps patients access them at a discounted price in a non-discriminatory marketplace. It was founded in 2018 and is based in Zug, Switzerland.
Missing: AEVOLVE's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: AEVOLVE's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
AEVOLVE Frequently Asked Questions (FAQ)
When was AEVOLVE founded?
AEVOLVE was founded in 2018.
Where is AEVOLVE's headquarters?
AEVOLVE's headquarters is located at Industriestrasse 47, Zug.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.